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Abstract: Increasing use of engineered nanomaterials (ENMs) in consumer products may
result in widespread human inhalation exposures. Due to their high surface area per unit
mass, inhaled ENMs interact with multiple components of the pulmonary system, and these
interactions affect their ultimate fate in the body. Modeling of ENM transport and clearance
in vivo has traditionally treated tissues as well-mixed compartments, without consideration
of nanoscale interaction and transformation mechanisms. ENM agglomeration, dissolution
and transport, along with adsorption of biomolecules, such as surfactant lipids and proteins,
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cause irreversible changes to ENM morphology and surface properties. The model presented
in this article quantifies ENM transformation and transport in the alveolar air to liquid
interface and estimates eventual alveolar cell dosimetry. This formulation brings together
established concepts from colloidal and surface science, physics, and biochemistry to provide
a stochastic framework capable of capturing essential in vivo processes in the pulmonary
alveolar lining layer. The model has been implemented for in vitro solutions with parameters
estimated from relevant published in vitro measurements and has been extended here to
in vivo systems simulating human inhalation exposures. Applications are presented for four
different ENMs, and relevant kinetic rates are estimated, demonstrating an approach for
improving human in vivo pulmonary dosimetry.
Keywords: nanoparticles; surfactant; agglomeration; adsorption; lipid vesicles; surfactant
proteins; Monte Carlo
1. Introduction
Engineered nanomaterials (ENMs) are becoming increasingly used in a wide array of consumer
products, leading to widespread exposures of human populations [1]. These products include sprays,
cosmetics and clothing, greatly enhancing the potential of exposure to ENMs for individuals of all
age groups. Based on information available in major ENM databases [1,2], inhalation exposures and
dermal exposures represent the two most important exposure routes for nanomaterials that are present
in consumer products. Royce et al. [3] estimated ENM inhalation exposures from use of representative
consumer products across the U.S. population and showed the resulting inhalation exposure to be orders
of magnitude higher than the background ambient exposure to the same materials. Inhalation also
presents the preeminent route for exposure to airborne particulates, such as pollen, soot, dust and smoke,
which are often in the sub-micrometer size range. Such inhalation exposures can lead to a variety of
adverse health effects, such as allergic reactions and cardiovascular effects [4].
Inhalation exposure results in a much easier access route for foreign particulate matter to the blood
circulation than other routes of exposure, despite the presence of a host of defense mechanisms in the
respiratory system. Starting from the mucus layer in the upper airways to the surfactant layer in the
alveolar region, along with alveolar epithelial cells and macrophages, inhaled particulate matter interacts
with a number of cells and biomolecules following its uptake into the respiratory system. Understanding
these interactions, starting with those in the pulmonary alveolar lining, is key to characterizing and
quantifying the ultimate biological effects of these exposures. Nanoparticle interactions with the
respiratory system involve processes at multiple scales, which require intensive investigation. The
pulmonary alveolar lining presents a critical area, where many important interactions take place for
nanoparticles. Unlike larger particles, which are preferentially deposited on the walls of the proximal
airways, a large proportion of nanoparticles end up in the distal airways and are deposited on the alveolar
lining. The interactions of these particles with the alveolar lining fluid lead to a multiscale cascade of
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effects propagating to the tissue and organ scale [5]. ENMs undergo agglomeration and dissolution
in any chemical or biological media, affecting the form, size and surface area of the particles, which
ultimately affect the uptake and clearance of the NPs and influence the eventual toxicodynamic effects
at the tissue and organism level.
1.1. ENM Interactions in Alveolar Lining Fluid
Nanoparticle (NP) transformation has been modeled by multiple researchers using physical theories
to assess cellular dosimetry. However, most of these studies have been performed for in vitro
systems to estimate particle dosimetry to cell cultures. The ISDD (In vitro Sedimentation, Diffusion
and Dosimetry) model [6] captures NP diffusion and settling for non-interacting particles and their
agglomerates. The ADSRM (Agglomeration-Diffusion-Sedimentation-Reaction Model) [7] considers
dynamic agglomeration and dissolution, along with diffusion and settling for in vitro systems, using a
direct simulation Monte Carlo method. The effort described here extends the ADSRM framework to
an in vivo setting, enabling the assessment of ENM interactions with various fractions of lipids and
surfactant proteins, which are present in the respiratory tract as constituents of pulmonary surfactant.
One of the most important features of the airway fluid in the alveolar region is the presence of
surfactant lipids, which are responsible for reducing surface tension and preventing the collapse of
the smallest airways [8]. Alveolar fluid is composed of about 80%–90% lipids, primarily DPPC
(dipalmitoylphosphatidylcholine), with the remaining 10% composed of surfactant proteins [5]. The
major classes of constituent lipids in pulmonary surfactant are summarized in Table 1. Four surfactant
proteins, SP-A, SP-B, SP-C and SP-D, have been identified in the pulmonary alveolar fluid. SP-B and
SP-C are known as surface-active proteins and are closely associated with surfactant lipids, assisting in
the formation of lipid bilayers at the air-liquid interface [9]. SP-A and SP-D are part of the humoral innate
immune system and help in immune response by attaching themselves to foreign particles and identifying
them for phagocytosis [5]. These critical components, i.e., phospholipids (PL) and the four surfactant
proteins, have been individually considered in this model implementation, as all of them interact with
inhaled particulate matter and affect relevant toxicodynamics.
Table 1. Properties of alveolar surfactant lipids.
Lipid Species Percentage composition * Molecular weight (kDa) **
Phosphatidylcholine (PC) 78 760.076
Phosphatidylethanolamine (PE) 3 471.609
Phosphatidylserine (PS) 5 547.17
Phosphatidylglycerol (PG) 7 787.383
Sphingomyelin (SM) 2 646.505
Cholesterol (CL) 5 400.637
* From Lung Surfactants, Notter, 2000 [5]; ** from Avanti Polar Lipids, [10].
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1.2. Multiscale Toxicodynamics
The work presented here is part of a wider research effort aimed at modeling toxicodynamics of
ENMs in mammalian respiratory systems, with the ultimate goal of characterizing human health risks
from inhaled ENMs. Mechanisms of toxicodynamic response at the cellular scale are affected by the
form, size and surface area of the ENMs [11,12]. It is well known that NP uptake by alveolar cells
depends on NP size, surface area and their surface chemistry, particularly adsorption of lipids and
proteins on their surface [13]. Consequently, any analysis of the residence time distribution, clearance
and biological response of NPs in any tissue system requires a detailed characterization of their form,
size and surface reactivity, as these change dynamically with time. The effects of transformation
processes were investigated for an in vitro culture of alveolar macrophages [14], demonstrating that
NP dosimetry to cells is significantly different when relevant transformation processes are considered.
Hinderliter et al. [6] also showed that the actual amount and form of the NPs reaching the cells over
time are markedly different when NP diffusion and settling area are taken into account. Researchers
have quantified NP transport, uptake and clearance in the respiratory system [15,16], but have not
considered dynamic changes in the form and size of the NPs. Mukherjee et al. [17] have also modeled
toxicodynamic effects of silver NPs in the mouse pulmonary system, considering effects of surfactant
adsorption, secretion, clearance and cellular uptake in vivo; however, dynamic transformation of NPs
was not considered. The interaction of NPs with lipids and proteins of the lung lining fluid is known to
affect their pulmonary toxicodynamics [13,18,19]. Wang et al. [20] and Monopoli et al. [21] have shown
that protein coronas on NPs modify their surface characteristics and are liable to affect their uptake by
cells. Wang et al. [20] found the protein corona to prevent intracellular NP degradation except inside
the lysosome, and so, inclusion of these key mechanisms is essential for any toxicodynamic model for
NPs. Blank et al. [22] attempted to recreate an alveolar air-liquid interface in vitro using human alveolar
epithelial cells. However, to date, there have been no published models quantifying ENM transformation
in vivo. It is almost impossible to realize the exact composition and dynamics of in vivo structures
and functions in vitro. This necessitates detailed in silico frameworks that will assemble and integrate
relevant in vitro and in vivo information to produce estimates of in vivo toxicodynamic effects. The
model developed here uses modules from ADSR Model [7] for diffusion, agglomeration and reaction
and introduces separate modules for the adsorption of proteins and lipid vesicles, for its applicability to
systems containing lipid and protein molecules, which are known to induce additional transformation
mechanisms for the ENMs. The model uses a direct simulation Monte Carlo (DSMC) scheme and
estimates various critical kinetic rates pertaining to ENM transformation in the respiratory airway, which
can be used to better quantify pulmonary toxicodynamics of ENMs. The approach described here is the
first of its kind to include NP to lipid and NP to protein interactions, along with dynamic NP transport
and transformation in vivo, to predict NP dosimetry in the mammalian respiratory system.
2. Methods
Mechanisms of transport and transformation in vivo are complicated by the presence of additional
biochemical substances and biological defense mechanisms of the tissue concerned. Inhaled particulate
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matter encounters the following structural and chemical entities in the alveolar region, which act as
biological defenses [23]:
• A concentrated layer of pulmonary surfactant, comprising mainly large aggregates of
phospholipids (PL) responsible for reducing surface tension at the air-liquid interface;
• A layer of alveolar fluid, which is essentially a mixture of PL (both large and small aggregates),
surfactant proteins (SP) and other lipids in an aqueous solution;
• A cellular layer comprising alveolar Type I and Type II cells along with alveolar macrophages
with tight junctions between them;
• A basement membrane followed by capillary endothelial cells marking the entrance to the
systemic circulation.
The alveolar region is also populated by alveolar lymphocytes (approximately 5%–10% of the
bronchoalveolar cells), which play an important role in host defenses within the alveoli [24]. Inhaled
ENMs interact differently with each of the entities listed above and, in turn, get transformed by their
interactions, which affects their ultimate distribution and toxicity [21]. The reactions of ENMs vary
according to their unique material chemistry. Silver ENMs, for which the model was developed and
implemented, are generally known to be highly reactive [25,26]. Silver gets readily oxidized in the
presence of dissolved oxygen [27] and can also suffer dissolution, as a result of which Ag+ ions are
produced in the medium [25,26]. Oxidative dissolution of Ag ENMs, which was modeled in the ADSRM
framework for in vitro media [7], has also been considered here. Dissolution is modeled as a function
of pH, ionic strength and the concentration of dissolved oxygen in the media. Silver ENMs have also
been observed to suffer sulfidation in a variety of environmental media [28,29]. Sulfidation of silver
nanowires in human alveolar epithelial cells was observed by Chen et al. [30], who showed it to be a
potential detoxifying mechanism in vivo. Liu et al. [29] showed that the kinetics of silver sulfidation are
limited by the presence of dissolved oxygen and sulfide groups in the media. The presence of sulfide
groups in the alveolar lining fluid being limited, sulfidation is not expected to have a predominant effect
on ENM transformation in the lining fluid. However, this is an aspect that needs further investigation,
along with the possible formation of other reaction products, such as silver oxides or silver chlorides.
The model described here employs a direct simulation Monte Carlo (DSMC) method to capture
ENM diffusion, settling, agglomeration, reaction and surfactant adsorption in vivo. The model is first
developed and implemented for in vitro lipid solutions, and key parameters are estimated utilizing in vitro
measurements from the literature. The model considers a slice of the alveolar lining layer and captures
the processes taking place after the inhaled ENMs are deposited on the surfactant layer in the alveolar
region. The entire set of processes considered in this model is shown schematically in Figure 1.
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Figure 1. Schematic representation of salient processes and mechanisms of transport,
transformation and interaction of inhaled engineered nanomaterials (ENMs) in the
pulmonary alveolar lining layer (diagram not to scale).
2.1. Surfactant Lipid Adsorption on ENMs
Inhaled particles interact with surfactant lipids from the instant they are deposited on the alveolar
surface. By the time the particles arrive at the surface of alveolar cells, they have been modified by the
adsorption of lipids and proteins present in the alveolar fluid layer. Bakshi et al. [31] and Schleh and
Hohlfield [32] have reported the formation of lipid bilayers on NPs immersed in lipid emulsions and have
found the thickness of this layer to be approximately 4 nm. Detailed kinetic models for these processes
are missing in the literature, because it is difficult to quantify such mechanisms in vivo. Adsorption of
lipid on to solid surfaces has been traditionally described using Langmuir kinetics [33]. In our previous
work (Mukherjee et al. [17]), we have described surfactant adsorption on silver ENMs in vivo using
first-order Langmuir kinetics based on in vitro measurements by Kendall et al. [13]. However, due to the
nanometer size range of ENMs, simple Langmuir kinetics of adsorption is only an approximation [33].
Mornet et al. [34] investigated the formation of lipid bilayers on silica NPs and found lipid “patches”
on the NPs a few minutes after incubation. They also observed small unilamellar vesicles (SUVs)
or liposomes adsorbed on the surface of the NPs, which later underwent deformation and rupture to
form lipid bilayers on the NPs. Mornet et al. [34] also found that the sizes of these SUVs were in the
10–100 nm range, which makes them comparable in size to ENMs. The interaction of these SUVs with
ENMs would be influenced by their mutual surface areas of interaction, their diffusion, and their surface
charge distribution, thus making the process inherently heterogeneous, non-uniform and affected by the
diffusion of the particles and lipid vesicles.
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Monte Carlo Simulation of Lipid Vesicle Adsorption
Lipid vesicle diffusion and adsorption on solid supports has been investigated extensively, due to the
wide application of “supported lipid bilayers” or SLBs in simulating cell membranes. Zhdanov and
co-workers [35,36] have used dynamic MC algorithms to simulate lipid vesicle diffusion, adsorption,
deformation and rupture on solid silica wafers immersed in lipid solutions. Their algorithm describes the
solid substrate as a square grid and randomly simulates vesicle attachment to grid locations based on the
vesicle size and available space on the solid grid. Zhdanov et al. also consider inter-vesicle interaction
and deformation of vesicles leading to rupture. It is not possible, computationally or otherwise, to
implement all of the complexities of the algorithm for multiple ENMs in solution, with each undergoing
random motion in the system. Therefore, we have utilized a simpler version of the algorithm employed
by Zhdanov et al. in which the adsorption of vesicles on to ENMs is based on the sizes of the interacting
vesicle and ENM and also on the available area on the ENM. Lipid vesicles are also assumed to deform
and rupture immediately after adsorption. The adsorption probability for a random vesicle on to a random
ENM is calculated using an exponential equation based on Zhdanov et al. [35]:
Pad = exp
(
− α · d
2
ves
f 2SA·d2ENM
)
(1)
Here, dves is the lipid vesicle diameter, dENM is the ENM diameter and fSA is the fractional exposed
(not covered by lipids) surface area of the ENM. The eventual likelihood of adsorption is affected
by the diffusion of the vesicles and ENMs and also by the probability of successful adsorption.
Zhdanov et al. [35] characterized the probability of an ENM and a vesicle colliding due to random
diffusion as Pdiff = 0.001 based on a diffusion coefficient of D = 8.7 × 10−10 m2/s [37]. An adsorption
attempt is considered successful if a randomly-selected number between 0 and 1 is less than Pad
Pad+Pdiff
.
The particular steps in the DSMC scheme for lipid adsorption are implemented as follows:
1. A random ENM is selected from the population in the control volume (CV);
2. A random lipid vesicle is selected based on the size distribution of vesicles;
3. Pad is calculated, such that if the selected ENM has zero exposed surface area, then Pad = 0; else
Pad is given by Equation (1);
4. A random number p is generated between 0 and 1;
5. Adsorption is considered successful if p < Pad
Pad+Pdiff
;
6. If adsorption is successful, the relevant properties of the particular ENM are updated with the
changed fSA and mass;
7. If the maximum number of adsorption steps has not been reached, then the steps are repeated from
Step (1).
Gross and Narine [38] found mouse BAL (Bronchoalveolar lavage) fluid to be composed of a 9%
“ultra-heavy” large aggregates, a 48% “heavy” fraction with large vesicles and some tubular myelin, and
a 43% “light” fraction consisting of small unilamellar vesicles (SUVs). SUVs in alveolar fluid have been
reported to vary in size between 20 and 50 nm [5]. Large vesicles (LUVs), which constitute the heavy
fraction, are between 50 and 500 nm [5]. A size distribution is constructed for lipid vesicles by fitting a
normal distribution within these reported size ranges (limits of the ranges are taken to be the upper and
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lower 95 percentiles of the distribution). SUVs and LUVs are randomly selected based on their relative
fraction in alveolar fluid. Adsorbed lipid vesicles are assumed to rupture after adsorption and to form a
lipid bilayer based on the surface area of the initial vesicles. Nordlund et al. [39] found only about 1% of
the adsorbed vesicles to be intact at the end of adsorption on silica NPs. Various properties of surfactant
and its constituent lipids are summarized in Table 2.
Table 2. Properties of the airway alveolar lining layer. BALF: bronchoalveolar lavage fluid;
PL: phospholipid; DMPC: dimyristoyl phosphocholine.
Property Value Reference
BALF density 1.04 g/mL Shelley, 1975 [40] (study based on male New Zealand rabbits)
Lipid conc. 328 µg/mL Shelley, 1975 [40] (study based on male New Zealand rabbits)
Protein conc. 212 µg/mL Shelley, 1975 [40] (study based on male New Zealand rabbits)
BALF vol. 10 mL/kg Meyer et al. [41] (study based on young humans)
PL density 1.108 g/mL Woodka et al. [42] (based on DPPC)
Ionic strength 245 mM Song et al. [43] (study based on 6–8 week CD1 mice)
pH 7.28 Song et al. [43] (study based on 6–8 week CD1 mice)
Viscosity 8.79 × 10−4 kg/(m·s) Stroumpoulis et al. [37] (based on DMPC solution)
Thickness 0.2 µm Bastacky et al. [44] (based on DMPC solution)
2.2. Surfactant Protein Adsorption on ENMs
Adsorption of proteins on solid surfaces has been investigated for a number of practical applications.
Proteins are part of all biochemical media, and any foreign particle entering the body gets coated with a
protein corona, which affects its eventual uptake and/or excretion. Uptake of silver ENMs by pulmonary
cells has in fact been shown to be affected by protein corona formation on the particles [21,45,46].
The mechanism of protein adsorption surfaces is known to be composed of the following steps [47]:
(1) diffusion of proteins to the surface; (2) actual adsorption on to the surface; and (3) subsequent
conformational changes in the protein structure. In the present model, the first two steps are explicitly
considered. Modeling conformational changes in protein structure would require a detailed proteomics
model, which is beyond the scope of this work. Pino et al. [46] have studied the kinetics of protein
adsorption and desorption on the surface of NPs. Zhdanov and Kasemo [48] have described a Monte
Carlo (MC) model for protein adsorption on solid surfaces, which has been extended here for ENMs in
solution. Two separate cases are considered: protein adsorption (1) under a diffusion-controlled regime
and (2) under an adsorption-controlled regime. The model algorithm selects the case based on the slower
or limiting process based on the conditions of the system at any given time. Under the adsorption-limited
regime, the adsorption probability is given by:
PAd = 2R
2Coka (2)
whereR is the radius of the particular protein headgroup,Co is the concentration of the protein in solution
and ka is the adsorption rate for the particular protein. The time step associated with the adsorption
process is given by ∆t = 1
PAd
. Under the diffusion-limited regime, the adsorption probability is given by:
PAd = 2R
2Co
√
piDt (3)
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whereD is the diffusivity of the protein in the solution and t is the system time. In this case, the time step
associated with the process is given by ∆t =
√
pit/D
CoA
, where A is the protein headgroup area. Adsorption
of proteins is however not irreversible and is actually a net result of adsorption and desorption [36].
Furthermore, adsorption of proteins cannot be independent of adsorption of other chemical species,
as the charged headgroups of proteins are liable to interact with charges already present on the ENM
surface. Lipid bilayers are known to interact with proteins through electrostatic interaction and, thus,
affect the adsorption and clustering of protein molecules [49]. Electrostatic interaction and the number
of charged-groups in contact would affect adsorption and the subsequent desorption of proteins from
surfaces [36]. Zhdanov and Kasemo [36] modeled protein adsorption and desorption on solid surfaces
in the presence of lipid bilayers and measured adsorption rates, ka, and desorption rates, kd, for various
values of surface coverage by lipid bilayers. Adsorption and desorption of surfactant proteins have been
considered in this model as functions of ENM surface coverage. A power-law model was fitted to the
measurements by Zhdanov and Kasemo [36] to estimate ka and kd as:
ka = k
0
a · (1 + βa · θna) (4)
kd = k
0
d · (1 + βd · θnd) (5)
where ka, kd are the adsorption and desorption rates for the proteins on to ENMs, θ is the fractional
surface coverage of ENMs by lipids and β and n are fitted parameters for adsorption and desorption.
Details of the estimation of these parameters for different SPs are included in Supplementary Materials.
A net rate defined as k′a = ka/kd was used in Equation (2) to simulate adsorption, so that the effects of
both adsorption and desorption could be simultaneously taken into account in the DSMC framework.
Pulmonary surfactant is composed of four types of proteins: SP-A, -B, -C and -D. The first three types
of proteins have been investigated considerably, but relatively little information is available for SP-D.
SP-A is the most abundant protein in pulmonary surfactant, accounting for 5% by weight of surfactant,
followed by SP-B and SP-C, which together account for 1.5% by weight [5]. Detailed properties of the
protein molecules have been summarized in Table 3.
Table 3. Properties of surfactant proteins.
Protein MW (kDa) * Length (nm) * Dia. (nm) * Density (g/cm3) + Conc. (µg/mL) ** D (109 m2/s)++
SP-A 32 20 20 1.41 132.5 0.093
SP-B 9 7.9 3 1.48 19.93 0.5474
SP-C 3.8 3.4 2 1.5 19.93 0.796
SP-D 42 92 92 1.4 39.64 0.0206
* From Lung Surfactants, Notter, 2000 [5]; + from Fischer et al. [50]; ** based on the percentage composition
from Notter [5] and total protein conc. in pulmonary alveolar fluid from Shelley, 1975 [40]; ++ diffusion
coefficient estimated using the Svedberg equation [51] (details in Supplementary Materials).
2.3. ENM Transport in Alveolar Lining Fluid
NP diffusion and settling have been modeled by Hinderliter et al. [6] (ISDD Model) and also recently
for silver ENMs by Mukherjee et al. [7] (ADSR Model) for in vitro media. As shown in both articles,
Nanomaterials 2015, 5 1232
gravitational settling has a major effect on ENM settling and eventual dosimetry for in vitro cell cultures.
However, it has been shown that, for nanoscale particles in vivo, the forces of surface tension exerted by
the surface-active alveolar lining layer are 2–3 orders of magnitude greater than gravitational forces [52].
Accordingly, gravitational forces have been replaced by surface tension for the in vivo implementation
of the model. For the in vitro implementations in this work, gravitational settling has been modeled
using Stokes’ law in a manner similar to Hinderliter et al. [6]. Surface forces acting on small particles
in the alveolar lining were mathematically analyzed by Schurch et al. [52]. The net force that causes the
immersion of the particles into the alveolar fluid is calculated as [52]:
Fs = 2piRγ·sin(φ)·sin(θ + φ) (6)
where R is the particle radius, γ is the surface tension at the alveolar air-liquid interface, θ is the contact
angle at the particle surface and φ is the angle formed between the contact point and the axis of the
particle. The surface force Fs can be equated to the drag force in the medium using Stokes’ law to obtain:
v =
γ
3µ
·sin(φ)·sin(θ + φ) (7)
Schurch et al. [52] found that for low values of surface tension (γ = 30 dyn/cm), such as those
experienced at the alveolar lining, the contact angle θ would have a value of 20◦ and that the value of φ
would be about 160◦.
2.4. ENM Agglomeration
ENM agglomeration has been modeled in a fashion similar to that in Mukherjee et al. [7] by
considering modified versions of Smoluchowski’s equations. However, lipid adsorption on the ENMs
causes surface modification, which has been found to dissuade agglomeration in silver ENMs [26]. This
has been taken into account by using the values of the zeta potential estimated by Leo et al. [26] for
DPPC-adsorbed silver ENMs. The zeta potential has been considered as a weighted function of surface
coverage by phospholipids as:
ζ = ζL·θ + ζo(1− θ) (8)
where ζo is the zeta potential of the ENM without lipid adsorption, ζL is the reduced zeta potential due
to lipid adsorption and θ is the fractional surface coverage of the ENM by lipids. The reduced zeta
potential ζL due to lipid adsorption is estimated from the data of Leo et al. [26], where zeta potentials of
silver NPs were measured with and without the addition of DPPC. ENM agglomeration is also known
to be affected by steric effects due to the presence of coating molecules. Leo et al. [26] reported that
despite a reduction in zeta potential, the addition of DPPC maintained the dispersed state of NPs and
did not promote agglomeration due to steric effects of the coating molecules. There was no such effect
in the results of Nordlund et al. [39], where the addition of lipids led to increased agglomeration. This
phenomenon was also observed by Kendall et al. [19] for particulate matter. This has been reconciled in
this model by introducing steric effects for coating molecules, which would produce additional repulsive
interactive forces. Damodaran [53] modeled repulsive interactions due to steric effects in proteins by
considering a repulsive energy due to steric effects that can be represented as:
Est = (kTnmL/s)·[(2L/d)2.25 − (d/2L)0.75] (9)
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where k is the Boltzmann constant, T is the absolute temperature, nm is the number of coating molecules
per unit surface area of the ENM, L is the chain length of the coating molecule, s =
√
1/nm is the
mean distance between coating molecules and d is the mean distance between interacting ENMs. The
steric repulsive energy (details in Supplementary Materials) is included in the calculation of repulsive
interactions as part of Smoluchowski’s equations, which consider both attractive van der Waals’ forces
and repulsive electrostatic forces of interaction.
3. Results and Discussion
The DSMC algorithm is implemented in a constant number mode. A population of 100 ENMs is
selected, and a control volume (CV) is defined, which contains these ENMs based on the concentration
of the system. At all times during the simulation, a number of internal and external coordinates
of the system of ENMs is recorded. The internal coordinates of ENMs refer to various dynamic
properties of the particles, such as position, diameter, surface coverage by lipid, adsorbed proteins and
agglomeration state. External coordinates refer to parameters of the medium, such as lipid and protein
concentration, ENM number concentration, temperature, density, viscosity, etc. Results of the ADSR
Model implementation for ENM transport and transformation are presented next, in two parts. The
first part concerns model implementation in vitro and estimation of key parameters pertaining to ENM
agglomeration and lipid adsorption. The model has been implemented for in vitro lipid solutions, and
simulation results are compared with measurements reported by Leo et al. [26] for silver NPs and
Nordlund et al. [39] for silica NPs. In the second part, the model has been implemented for the human
alveolar lining layer, and predictions of the model are presented for in vivo ENM transformation. Various
critical kinetic rates are also estimated based on the in vivo results.
3.1. In Vitro Implementations
The ADSR Model described in the present article was implemented for an in vitro system based on
the works by Leo et al. [26] and Nordlund et al. [39]. Some features of the model implementation were
exclusively applied for the in vitro cases as follows:
• Lipid concentration is considered to vary dynamically from the initial values in solution. Vesicle
diffusivity was appropriately modified. For in vivo systems, the levels of lipid in alveolar lining
are maintained relatively constant by alveolar cells via constant secretion and removal.
• DPPC vesicle size distribution and concentration have been considered based on the commercially
available formulations used in the relevant studies, rather than on the properties of actual biological
surfactant.
• Gravitational settling has been considered, rather than surface-active transport, unlike the situation
in the actual alveolar lining, where surface tension-aided transport far outweighs gravitational
transport (discussed in the Methods).
Leo et al. [26] used citrate-coated silver NPs (AgNPs) in solution (with and without DPPC) at varying
values of pH and followed the change in particle size and silver dissolution over a span of seven days.
Values of various ENM and media properties were appropriately selected to mimic the in vitro system
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used by Leo et al., and these are summarized in Table 4. Figure 2 shows comparisons between model
predictions and in vitro measurements from Leo et al. [26] for the mean diameter of AgNPs in solution
after seven days of incubation in media of different pH, with and without the addition of DPPC. Mean
diameter has been calculated considering the entire particle population from in vitro measurements
reported by Leo et al. and taking the number-weighted mean of the particle diameters. The model
captures the phenomenon of increased agglomeration due to lower values of pH reasonably well. The
measurements of Leo et al. also demonstrate decreased agglomeration due to DPPC despite the lowering
of surface zeta potentials due to lipid adsorption. This has been attributed to the influence of steric
factors. Accordingly, a steric factor has been included in the estimation of repulsive interaction energies
for coated ENMs through Equation (9). Appropriate modulation of values of the adsorption probability
α in Equation (1) and the steric factor, ηS in Equation (9), allows the model results to match the in
vitro measurements. The final values of the estimated parameters are summarized in Table 4. Figure 3
compares model predictions and in vitro measurements for dissolution of AgNPs in media with and
without DPPC. The model shows reduced dissolution when DPPC is added due to increased surface
coverage of the ENMs by DPPC molecules, which reduces the rate of silver oxidation and dissolution
from the AgNP surface. Furthermore, the inhibitory effect of DPPC on Ag dissolution increases with
time, as AgNP surface coverage increases. It is also seen that the effect of lipid adsorption is much less
than the effect of pH, most probably due to gravitational settling. AgNPs with large amounts of adsorbed
DPPC have a greater tendency to settle and are thus removed from the solution.
Nordlund et al. [39] used silica NPs (SiNPs) (without coating) to study lipid adsorption from a
solution of DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine). DOPC has a similar zwitterionic polar
headgroup as DPPC, with oppositely-charged amine and phosphorus groups next to each other [10].
Interactions between DOPC molecules and negatively-charged SiNPs are expected to be similar to those
between DPPC and citrate-stabilized AgNPs. However, as reported by Leo et al. [26], the presence
of citrate groups might add to the steric effects, which are absent in the case of SiNPs. In fact,
Nordlund et al. [39] reported that the SiNPs have an increased tendency to agglomerate in the presence
of DOPC, which suggests lesser steric effects than for NPs with coating. The ADSRM model was
implemented for the in vitro system corresponding to the study with SiNPs and with different values
of lipid-to-NP ratios as performed by Nordlund et al. [39]. However, in that study, the SiNPs were
incubated with DOPC vesicles for 1 h, accompanied by stirring. This would prevent settling of particles,
and, accordingly, settling was not considered here. Appropriate parameter values required for this
implementation are summarized in Table 4. In the study by Nordlund et al. [39], DOPC was mixed with
fluorescein, and the associated fluorescence on the SiNPs due to adsorbed DOPC was measured by flow
cytometric analysis. Figure 4 compares model predictions of fraction of particles with adsorbed DOPC
and in vitro measurements from Nordlund et al. [39] for ten values of Av/Ap, which represent the initial
surface area ratios of vesicle to NP. Figure 5 compares the predicted average amount of DOPC adsorbed
on SiNPs in solution with in vitro measurements of average fluorescence from Nordlund et al. [39].
The results have been normalized by the value of mean fluorescence with no DOPC added to correct
for fluorescence produced by SiNPs themselves. This model implementation has been carried out along
with the appropriate selection of values for adsorption probability α in Equation (1) and the steric factor,
ηS in Equation (9). ηS has a lower value than that in the earlier implementation due to the absence of
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coating on the SiNPs. Figure 6 compares the model-predicted average diameter of SiNPs in solution with
measurements of fluorescence with increasing vesicle-to-particle surface area ratios. Average diameter
has been calculated by considering the entire particle population from in vitro measurements reported by
Nordlund et al. and taking the number-weighted mean of the particle diameters.
Table 4. Parameters used for model implementations.
Parameters Leo et al., 2013 [26] Nordlund et al., 2009 [39] In Vivo Implementation
System Eppendorf tube NR Alveolar lining
System volume 4 mL NR 10 mL/kg BW [41]
ENM type Ag NP Silica NP Ag NP
ENM coating type Citrate (C) None Citrate (C), PVP
Coating molecular weight (mol. wt.) 258 None 258 (C), 10,000 (PVP)
Initial ENM diameter (nm) 20 600 20, 110
ENM density (g/mL) 10.49 2 10.49
ENM concentration (mg/L) 25 3000 NA *
Ionic strength (mM) 0.1 100 245 [43]
pH 3, 5, 7 7.4 7.28 [43]
Initial ENM zeta potential (mV) −18.2, −22.5, −32.5 −25 [54] −32.5
Dissolved O2 (mg/L) ** 8.96 8.96 8.96
Temperature 37 ◦C 22 ◦C 37 ◦C
Adsorption probability, α 0.004 0.001 0.004
Steric factor, ηS 2.35 1 2.35 (C), 10.6 (PVP)
* In vivo dosage was simulated as inhaled aerosolized ENM present in consumer products [3]; ** saturated
O2 conc. for solutions exposed to atmospheric pressure [25]; values, unless otherwise referenced, are from the
original studies; NR = not reported.
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Figure 2. Comparison of model predictions of silver ENM mean diameter (shown as stars)
with in vitro measurements (shown by bars) from Leo et al. [26] for citrate-coated silver
ENMs (L20; initial mean diameter = 20 nm; other ENM properties in Table 5) incubated
with and without dipalmitoylphosphatidylcholine (DPPC) for 7 days.
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Figure 3. Comparison of model predictions of percent Ag dissolved in solution with in
vitro measurements from Leo et al. [26] for citrate-coated silver ENMs (L20; initial mean
diameter = 20 nm; other ENM properties in Table 5) incubated with and without DPPC for
up to 14 days (results for pH 3 in red, for pH 5 in blue and for pH 7 in black).
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Figure 4. Comparison of model predictions (red line) of fraction of NPs (N600; initial
mean diameter = 600 nm; other ENM properties in Table 5) with adsorbed lipids after 1 h
of incubation, with in vitro measurements (black squares) from Nordlund et al. [39] for
different values of surface area ratios of lipid vesicle to particle.
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Figure 5. Comparison of model predictions (red line) of the time change in the amount
of adsorbed lipids after 1 h of incubation, with in vitro measurements (black squares) from
Nordlund et al. [39] for different values of surface area ratios of lipid vesicle to NP (N600;
initial mean diameter = 600 nm; other ENM properties in Table 5).
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Figure 6. Comparison of model predictions (shown as stars) of the average size of silica
NPs (N600; initial mean diameter = 600 nm; other ENM properties in Table 5) after one
hour of incubation with in vitro measurements (shown as bars) from Nordlund et al. [39] for
different values of surface area ratios of lipid vesicle to particle.
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Table 5. Properties of silver ENMs used in the model implementations.
NP Coating Core Material Density (g/cm3) Mol. Wt. Coating Mol. Wt. Zeta Potential (mV) Ref.
L20 Citrate Ag 10.49 108 258 −39.2 [26]
N600 None SiO2 10.49 108 258 −39.2 [39]
C20 Citrate Au 10.87 115.3 258 −44.3 [7,55]
P20 PVP Au 10.87 115.3 10,000 −38.2 [7,55]
C110 Citrate Au 10.49 108.04 258 −45.2 [7,55]
P110 PVP Au 10.49 108.04 40,000 −31.6 [7,55]
3.2. In Vivo Implementation
The ADSR Model developed in the present article was also implemented for the human alveolar
lining layer, simulating ENM dosimetry after inhalation exposure. This formulation specifically helps us
estimate key kinetic parameters of ENM transformation and transport in the alveolar lining, which can
inform toxicodynamic models relevant to the human pulmonary system. The following modifications
were incorporated into the model to reflect conditions relevant to the in vivo system:
• The ENM dose to the alveolar region is based on an inhalation dose for an adult human.
• Airway dosimetry of ENMs based on alveolar deposition is estimated by the software MPPD [56].
• Gravitational settling is replaced by surface-tension-assisted transport of particles towards the
cellular layer.
• The concentration of lipids and proteins is considered constant due to homeostasis maintained by
constant secretion from alveolar cells.
Various parameters of the airway and the alveolar lining layer are summarized in Table 2. ENM dose
is considered to be delivered by a single breath by an adult human, breathing in an ENM cloud with
a reference concentration of 0.14 mg/m3. The reference concentration is obtained from Royce et al. [3]
and is based on the maximum concentration in the immediate breathing zone after spraying of a bathroom
cleaner containing silver ENMs in an indoor residential microenvironment. The mass concentration is
converted to the number concentration based on the size distribution of the ENMs used, and the ENMs
are all considered to be monomers initially. Four types of silver ENMs are used in this implementation
to test the effect of ENM and coating type, specifically 20- and 110-nm silver ENMs with citrate and
PVP (polyvinyl pyrrolidone) coatings. Wang et al. [55] used these four types of NPs to test their
dosimetry in cell culture plates. The ENMs are referred to as C20 , C110, P20 and P110, respectively,
and their properties are summarized in Table 5. Human airway dosimetry modeling is performed using
the MPPD software package [56], which considers age-dependent changes in airway morphology to
calculate particle deposition based on particle size and density in different regions of the lung. The entire
population of ENMs reaching the alveolar region is divided by the known air-exchange area of alveoli
(70 m2 [32]) in an adult human lung. Various parameters of the mammalian alveolar lining layer are
summarized in Table 2. The ADSR Model is implemented through a constant number DSMC algorithm
consisting of the following steps:
1. A constant number (N = 100) of ENMs is selected, and the associated alveolar area is calculated.
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2. The volume of the starting control volume (CV) is calculated based on a uniform average thickness
of the alveolar lining layer.
3. The ENMs are initially all considered to be deposited at the top of the CV.
4. ENMs are considered to be monomers, as there is negligible chance for agglomeration in the
airway before coming in contact with a surface.
5. Diameters and all other internal coordinates of the ENMs in the CV are estimated.
6. Various modules of the model—agglomeration, transport, adsorption, desorption and
reaction—are successively implemented as described in detail in the Methods Section.
7. Time is advanced by ∆t based on the slowest step among all processes.
8. New CV is established based on the constant number N.
9. ENM and media property values are saved, and the steps are run again from Step 5 as
described above.
The model simulation stops when the concentration of ENMs in the alveolar lining layer drops to 1%
or less of its initial concentration. Since the transport of ENMs through the alveolar lining layer is a
relatively fast process, compared to the earlier implementations for in vitro media, the model involves a
relatively small number of steps to complete. The bottom of the alveolar lining and the location of the
alveolar cellular surface is considered the bottom of the CV and where the ENMs settle. The current
model implementation predicts the state, number and condition (adsorbed surfactant lipids and proteins)
of ENMs present at the bottom of the lining layer after inhalation, which would ultimately affect their
uptake by the alveolar cells and macrophages.
3.2.1. Estimation of Kinetic Parameters
Implementation of the ADSR Model for an actual in vivo system allows one to test the interplay
of various parameters that have been estimated from in vitro studies. The results allow the estimation
of average kinetic rate constants, which can then be used for higher level (tissue and organism level)
models. Figure 7 shows the change in ENM diameter for the different types of ENMs considered, due
to agglomeration. Larger ENMs (C110 and P110) seem to have a higher rate of agglomeration than
the smaller ENMs. This might be counter-intuitive, since most studies [55] have demonstrated smaller
particles to have a higher tendency to agglomerate than larger particles. However, such tissue-level
studies compare particles based on identical mass doses of different particles. Equal mass doses of larger
and smaller particles would result in significantly larger numbers of the smaller particles, resulting in a
far higher number concentration, which would enhance the number of probable collisions between the
particles per unit time. On a per particle basis, a larger ENM would have a higher van der Waals’ force of
attraction than a smaller ENM, which explains the observed higher rates of agglomeration for C110 and
P110. Among ENMs of the same size, PVP-coated ENMs have a slightly lower rate of agglomeration
due to increased steric stabilization (quantified by the parameter ηS) by PVP molecules, as compared to
citrate molecules. The results shown in Figure 7 are used to estimate an average rate of agglomeration as
the increase in diameter per time unit. However, the model being stochastic, there are random variations
in the results. The ADSRM model is run 10 times for each ENM, and various kinetic parameters are
estimated for each run. The means of the estimated values are summarized in Table 6. Transport driven
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by gravitational forces tends to favor larger NPs as shown in Figure 8. However, due to ENM transport
across the alveolar lining being ultimately driven by surface tension, there is no discernible difference in
the transport rates among the different types of ENMs. Therefore, the average transport velocities for the
different ENMs across the alveolar lining layer (Table 6) are identical. Figure 9 shows fractional surface
coverage of the ENM surface due to surfactant phospholipid (PL) adsorption. Smaller ENMs seem to
be coated with lipids faster, due to the fact that a single interaction between a vesicle and a smaller
ENM might completely cover the smaller ENM, while for a larger ENM, this might require multiple
interactions. Table 6 shows the rates for PL adsorption, which has been normalized by the surface area
of the ENMs to cancel the effect of size. The PL adsorption rate has been quantified as the amount of
PL adsorbed per unit surface area per time and is estimated based on the fractional surface coverage
and considering a uniform PL bilayer of 4 nm on the ENMs. Comparison of the values shows that P20
has a slightly lower value (even lower than P110) of adsorption rate, which might be due to the higher
number of coating molecules per unit surface area (Table S2 in Supplementary Materials) on P20 than
on P110. Figure 10 shows the number of protein molecules adsorbed per ENM. SP-B and SP-C have a
higher prevalence due to their close association with surfactant lipids. Furthermore, larger ENMs (C110
and P110) have a higher tendency to attract surfactant proteins due to larger available surface area.
Table 6. Estimated parameter values for ENM kinetics in vivo.
Parameter C20 C110 P20 P110
Agglomeration rate (nm/s) 5.423× 10−6 3.483× 10−5 5.82 × 10−6 3.986 × 10−5
Transport rate (m/s) 7.481× 10−5 7.481× 10−5 7.481 × 10−5 7.481 × 10−5
Dissolution rate (per s) 4.25 × 10−11 6.375× 10−9 5.525× 10−14 9.52 × 10−13
Phospholipid (PL) adsorption rate (ng/nm2/s) 1.053× 10−7 1.304× 10−7 9.06 × 10−8 1.166 × 10−7
Surface active (SA) protein adsorption rate (nmol/nm2/s) 3.36 × 10−18 1.61 × 10−19 3.233× 10−18 1.29 × 10−19
Collectin (C) adsorption rate (nmol/nm2/s) 2.66 × 10−18 1.55 × 10−19 3.737× 10−18 8.472× 10−20
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Figure 7. ADSRM simulation results of the change in mean ENM diameter (times initial
mean diameter) for four different types of silver ENMs of diameters of 20 and 110 nm (other
ENM properties in Table 5).
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Figure 8. ADSRM simulation results of fractional distance covered by ENMs (ENM
diameters of 20 and 110 nm; other ENM properties in Table 5) across the alveolar lining
thickness (a value of one represents the bottom of the lining layer at the cellular surface, and
a value of zero represents the top of the surfactant layer).
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Figure 9. ADSRM simulation results of mean fractional surface coverage of ENMs (ENM
diameters of 20 and 110 nm; other ENM properties in Table 5) by adsorbed surfactant
phospholipids for four different types of silver ENMs.
Nanomaterials 2015, 5 1242
SP-A SP-B SP-C SP-D
0
5
10
15
20
25
P
ro
te
in
 m
ol
ec
ul
es
 p
er
 E
N
M
 
 
C20
P20
C110
P110
Figure 10. ADSRM simulation results of surfactant protein molecules adsorbed on different
ENMs (ENM diameters of 20 and 110 nm; other ENM properties in Table 5).
3.2.2. Sensitivity Analysis
A local sensitivity analysis was conducted to understand the effect of various parameters on the final
model results. The sensitivity analysis included a total of 17 parameters, which can be classified into
three groups. The first group had seven parameters corresponding to the properties of the alveolar
interface layer and included bronchoalveolar lavage fluid (BALF) density, BALF viscosity, BALF pH,
BALF temperature, BALF ionic strength, alveolar layer thickness and alveolar surface area. The second
group included four parameters corresponding to phospholipid (PL) adsorption: PL adsorption rate
constant (α), PL vesicle diffusion probability (Pdiff), PL density and PL vesicle diffusivity. The third
group consisted of parameters reflecting properties of the NPs and included: NP material molecular
weight, NP material density, NP surface zeta potential, coating density, coating molecular weight and
reaction rate constant. The sensitivity analysis was conducted by changing the value of one parameter at
a time by 1%, while keeping values of all other parameters at their nominal values. The sensitivity index
was calculated using the equation: Si = (V *i −V )/(V.∆pi), where V represents the value of the particular
variable corresponding to nominal values of all parameters, V *i represents the value of the variable with
the changed value of the parameter, pi, and ∆pi represents the fractional change in the value of pi. Values
of output variables might increase or decrease with the increase in values of parameters, and accordingly,
the corresponding sensitivity indices might be positive or negative. Furthermore, due to the stochastic
character of the model, values of the output variables change on every iteration. Accordingly, the model
was run for 10 iterations, and the mean of the sensitivity indices was taken. Figure 11 shows the results
of the sensitivity analysis for three output variables: agglomeration rate, transport rate and dissolution
rate. The individual indices have been normalized by the highest valued index for a particular output
variable. Overall, it can be said that the properties of the BALF strongly affect agglomeration rate of the
NPs. For the transport rate, only BALF density and ionic strength seem to have a substantial effect. For
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the dissolution reaction rate, only BALF temperature and ionic strength have an effect. This should be
expected, since the dissolution reaction is a chemical process and is affected by temperature and the ionic
concentration of the medium. It can also be observed in Figure 11 that the stochastic parameters—PL
adsorption rate constant and PL vesicle diffusion probability—have a relatively low effect on the output
variables. The third group of parameters, consisting of physicochemical properties of NPs, is found to
strongly affect agglomeration of NPs and only affect transport moderately.
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Figure 11. Sensitivity indices for 17 parameters corresponding to the in vivo implementation
of ADSRM for three different outputs: (a) agglomeration rate; (b) transport rate; and
(c) dissolution rate.
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4. Conclusions
The work described here presents an extension and implementation of the ADSR Model [7] for
the pulmonary alveolar lining layer. An earlier version of the model had been developed [7] for
in vitro cell cultures to assess ENM dosimetry to the cells. The problem of dosimetry is, however,
more critical for in vivo toxicodynamic models. Generally, toxicokinetic and toxicodynamic models
for NPs [15,17,57] approximate various physiological compartments via well-mixed compartments and
mechanisms by linear, first-order kinetic rates. However, due to the size and unique properties of ENMs,
their interactions with various biological molecules and cells often cannot be described by simple kinetic
equations. This paper describes a stochastic DSMC algorithm to model the interactions of ENMs with
each other and with biological agents in the alveolar lining layer, which forms a critical first line of
defense against inhaled particulate matter. The model considers the agglomeration, transport and reaction
of ENMs as treated in the earlier version of the model [7], and also includes surfactant lipid and protein
adsorption on ENMs. Surfactant adsorption has been identified as a critical mechanism that regulates
particle toxicodynamics and affects further uptake and clearance of the ENMs. Surfactant proteins have
multiple roles, including promoting surface activity (SP-B, SP-C) and inducing immune response (SP-A,
SP-D). All four protein types have been separately identified, and their adsorption on the ENMs is
modeled here using the DSMC scheme. The model was first implemented for in vitro systems in order
to parameterize the extended formulation utilizing published data. The model was subsequently applied
to the human alveolar lining layer, considering an inhalation dose of four types of ENMs, to investigate
the effects of size, as well as surface coating type.
In vivo toxicodynamics of NPs consists of multiple interactions between the particles themselves
and also with cells and biochemical molecules. These interactions lead to agglomeration and reactions
causing changes in the state of the particles. Changes in the shape, size and agglomeration state of
NPs are known to affect the interaction of these NPs with various cells of biological systems [12,58].
The model described here considers the most important interactions and mechanisms relevant to particle
toxicodynamics in the alveolar lining layer. The model utilizes mechanistic information available in the
scientific literature and also relevant in vitro studies to simulate a phenomenon for which, at present,
there are no in vivo measurements. However, the process of surface modification of NPs in vivo is
very complex and involves a number of proteins, salts and other biomolecules [59]. The proteins
corona on the NPs can also be distinguished into the hard corona and the soft corona, each of which
have individual kinetics [21]. All of these interactions affect cellular uptake and trafficking in ways
that are not yet fully elucidated. Future research into nano to bio interactions will probably produce
novel information, which can be incorporated into multiscale frameworks, such as ADSRM, leading
to improved modeling formulations. This will help us compare and contrast the effects of multiple
processes and interactions simultaneously.
In vivo characterization of particokinetics in the pulmonary regions is extremely difficult due to the
small size and time scales, which prevent an accurate and quantifiable description. The model described
here will be utilized to inform and improve tissue-scale pulmonary toxicodynamic models involving
ENMs. Based on a sensitivity analysis, it was found that the properties of the alveolar lining, the
properties of the NPs, and those of the phospholipid vesicles of the alveolar lining are mostly responsible
Nanomaterials 2015, 5 1245
for the variation in NP kinetics in the alveolar layer. While the biological properties of the alveolar lining
are fairly well characterized, NP properties exhibit wide variability. This calls for more accurate and
reproducible estimation of NP properties, especially density, surface zeta potential and coating efficiency.
Supplementary Materials
Supplementary materials can be accessed at: http://www.mdpi.com/2079-4991/5/3/1223/s1.
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